PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings328 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

ELI LILLY & CO

23.5M$11B9.2%$104.89+337.07%
19 qtrssince 2018-Q4
Decreased
0

BIOGEN IDEC INC

16M$4.6B3.8%$292.51-3.55%
19 qtrssince 2018-Q4
Increased
58

MICROSOFT CORP

10.6M$3.6B3.0%$93.93+250.01%
19 qtrssince 2018-Q4
Decreased
0

AMGEN INC

14.7M$3.3B2.7%$153.26+32.60%
19 qtrssince 2018-Q4
Decreased
0

FEDEX CORP

13.2M$3.3B2.7%$145.69+62.67%
19 qtrssince 2018-Q4
Decreased
0
AZNAZN
ADR

ASTRAZENECA PLC

44.1M$3.2B2.6%$62.66+116.95%
19 qtrssince 2018-Q4
Decreased
0

ADOBE INC

6.1M$3B2.5%$226.24+116.14%
19 qtrssince 2018-Q4
Decreased
0

KLA CORP

6.1M$3B2.5%$8.14+481.25%
19 qtrssince 2018-Q4
Decreased
0

TEXAS INSTRUMENTS INC

15.9M$2.9B2.4%$76.19+115.34%
19 qtrssince 2018-Q4
Decreased
0

TESLA INC

9.2M$2.4B2.0%$214.88+19.83%
19 qtrssince 2018-Q4
Decreased
0

MICRON TECHNOLOGY INC

38M$2.4B2.0%$30.81+106.26%
19 qtrssince 2018-Q4
Decreased
0

INTEL CORP

70.5M$2.4B2.0%$38.57-16.39%
19 qtrssince 2018-Q4
Increased
51

ALPHABET INC-CL A

19.6M$2.3B2.0%$94.45+25.15%
19 qtrssince 2018-Q4
Decreased
0
SONYSONY
ADR

SONY CORP-SPONSORED ADR

22.9M$2.1B1.7%$9.23+92.42%
19 qtrssince 2018-Q4
Decreased
0

BOSTON SCIENTIFIC CORP

37.4M$2B1.7%$35.11+51.79%
19 qtrssince 2018-Q4
Decreased
0

WELLS FARGO & CO

44.4M$1.9B1.6%$36.98+6.49%
19 qtrssince 2018-Q4
Decreased
0

SOUTHWEST AIRLINES CO

50.1M$1.8B1.5%$42.56-20.16%
19 qtrssince 2018-Q4
Decreased
0

THERMO FISHER SCIENTIFIC INC

3.1M$1.6B1.3%$221.73+130.23%
19 qtrssince 2018-Q4
Decreased
0

BIOMARIN PHARMACEUTICAL INC

18.4M$1.6B1.3%$83.37+6.67%
19 qtrssince 2018-Q4
Increased
51

ALPHABET INC-CL C

13M$1.6B1.3%$95.04+25.33%
19 qtrssince 2018-Q4
Decreased
0
$119.7B
AUM
328
Positions
Q2 2023
Filing
Rating · 4.5
Quarterly Portfolio Change
-8%Q1'22$132.6B-16%Q2'22$111.9B-8%Q3'22$103.3B+6%Q4'22$109.2B+5%Q1'23$114.7B+4%Q2'23$119.7B
Activity profile
$ moved · Q2'23
New0%Increased12%Decreased87%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.5 years
<1Q1%1-4Q6%1-2Y9%2Y+84%

PRIMECAP MANAGEMENT CO/CA/ manages $119.7B across 328 positions as of Q2 2023. Top holdings: LLY (9.2%), BIIB (3.8%), MSFT (3.0%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 4.5/5.0.

Q2 2023 Summary

Active quarter - 4 new positions, 7 exits, 58 increased. Top move: BIIB (INCREASED, conviction 58). Portfolio: $119.7B across 328 positions.

Top holdings by portfolio weight

Total AUM$120B
LLY9.23%
BIIB3.81%
MSFT3.01%
AMGN2.73%
FDX2.73%
AZN2.64%
ADBE2.50%
KLAC2.47%
TXN2.40%
TSLA2.01%
Other2.00%

Portfolio allocation by GICS sector

Sectors11
Healthcare30.36%
Technology28.55%
Industrials12.19%
Consumer Cyclical9.41%
Financial Services7.05%
Communication Services5.57%
Unknown4.62%
Basic Materials0.93%
Energy0.81%
Consumer Defensive0.50%
Other0.02%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Technology, Industrials
Compare DNA across all funds
7-dimension quality assessment
Elite(4.5 / 5.0)
Track Record93
Conviction35
Concentration64
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
COPCOPCONOCOPHILLIPS
Q3 2024 Q2 2026+8.7M shares+$872.8M
8Q
USFDUSFDUS FOODS HOLDING CORP
Q3 2024 Q2 2026+3.9M shares+$400.8M
7Q
SCHWSCHWSCHWAB (CHARLES) CORP
Q4 2024 Q2 2026+24.1M shares+$2.3B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used